Publications
-
Immunogenicity, Efficacy and Twelve-Month Storage Stability Studies of a Lyophilized Rabies mRNA VaccineRead More
-
Development and characterization of a miRNA-responsive circular RNA expression system with cell type specificityRead More
-
A penta-component mpox mRNA vaccine induces protective immunity in nonhuman primatesRead More
-
Engineered mRNAs With Stable Structures Minimize Double-stranded RNA Formation and Increase Protein ExpressionRead More
-
Efficient circularization of protein-encoding RNAs via a novel cis-splicing systemRead More
-
Efficacy, immunogenicity, and safety of a monovalent mRNA vaccine, ABO1020, in adults: A randomized, double-blind, placebo-controlled, phase 3 trialRead More
-
Rapid development of double-hit mRNA antibody cocktail against orthopoxvirusesRead More
-
Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccineRead More
-
Construction and immunogenicity of an mRNA vaccine against chikungunya virusRead More
-
Rational development of a combined mRNA vaccine against COVID-19 and influenzaRead More
-
Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open‐label, and single‐arm Phase 1 studyRead More
-
Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adultsRead More
-
RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variantsRead More
-
Lipid nanoparticle-encapsulated mRNA antibody provides longterm protection against SARS-CoV-2 in mice and hamsterRead More
-
Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variantRead More
-
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trialRead More
-
Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primatesRead More
-
A Thermostable mRNA Vaccine against COVID-19Read More
